Who is most likely to benefit from early-life antibiotic exposure?

Is there any benefit to early-life antibiotics?

The short answer is no — the evidence does not show that early-life antibiotics improve long-term health outcomes. Instead, the studies consistently point to small but measurable increases in risk for several conditions. For example, a large Swedish study of over 720,000 children found that antibiotics in the first year of life were linked to a 52% higher risk of atopic dermatitis (eczema), though this dropped to 24% when comparing siblings, suggesting family factors play a role [5]. Similarly, a Danish study of nearly 1 million children found that antibiotics in the first year were associated with a 40% higher risk of Crohn's disease, but the absolute risk was still very low — 0.16 per 1,000 children by age 11 [6]. The key takeaway: any risks are small, and the infection being treated may be the real driver of later problems.

The picture is clearest for preterm infants, where antibiotics are often given preventatively. A large Chinese study of nearly 25,000 preterm infants found that early antibiotics themselves were not linked to death or necrotizing enterocolitis (a severe gut condition), but prolonged use (especially broad-spectrum) was tied to higher mortality [1]. Another French study of very preterm infants at low risk of infection found that early antibiotics were linked to a 2.7-fold higher odds of severe brain lesions and a 2.3-fold higher odds of lung disease [8]. These findings suggest that in the most vulnerable babies, the risks of antibiotics may outweigh the benefits when infection risk is low.

Does the type or duration of antibiotics matter?

Yes — and this is one of the clearest messages from the research. The risks are not the same for all antibiotics; longer courses and broad-spectrum drugs are consistently worse. In the Chinese preterm study, prolonged antibiotic treatment (more than a few days) was linked to nearly 3 times higher odds of death, and broad-spectrum antibiotics specifically raised that risk to 5 times [1]. A US study of over 183,000 children found that each additional course of antibiotics before age 4 was linked to earlier and higher body mass index (BMI) rebound — a marker for later obesity — with the strongest effects seen in children who had 4 or more courses [7].

A randomized trial in full-term newborns directly compared three common antibiotic regimens and found that amoxicillin plus cefotaxime caused the biggest disruption to the gut microbiome, reducing beneficial Bifidobacterium and increasing potentially harmful bacteria, while penicillin plus gentamicin had the least impact [11]. This matters because a disrupted microbiome in early life is thought to be a key pathway linking antibiotics to later allergies, asthma, and weight gain. The Australian study of over 4,300 children found that any antibiotic before age 2 doubled the risk of persistent asthma, and second-generation cephalosporins were particularly risky [9].

Is it the antibiotics or the infection?

This is the most important caveat. Many studies that find links between antibiotics and later problems fail to account for the fact that the infection itself — or shared family genetics — could be causing both the need for antibiotics and the later condition. The strongest evidence on this comes from sibling-controlled studies, which compare brothers and sisters who are genetically similar and share the same home environment. A meta-analysis of 30 studies (over 7 million participants) found that early-life antibiotics were weakly linked to autism (9% higher odds) and ADHD (19% higher odds), but when sibling-controlled studies were analyzed separately, those links completely disappeared [3][4]. Another meta-analysis confirmed this pattern for both autism and ADHD [10].

The same pattern holds for eczema: the Swedish sibling analysis showed that the apparent link between prenatal antibiotics and childhood eczema vanished when comparing siblings [5]. For asthma, the story is more mixed — the Australian study did not use sibling controls, so the 2-fold increased risk may still be partly due to genetics or the infection [9]. What this means for parents: if your child needs antibiotics for a confirmed bacterial infection, the benefits of treating that infection almost certainly outweigh the very small, uncertain risks of later problems. The real danger is using antibiotics unnecessarily for viral infections, where they do nothing and still carry these small risks.

About These Sources

This answer is built on 11 peer-reviewed studies — published from 2021 to 2025, 4 from 2024 or later, 9 in Q1 journals, collectively cited 492 times — selected as the most relevant from 15 studies that passed quality screening, drawn from 63 papers retrieved from a database of over 500 million.

Sources used in this answer

Related research questions